Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Show Submenu For Accessing medicines
Medicine recommendations
Access to medicines in Wales
Make a submission
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Sodium valproate information hub
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Who we are
What we do
Our committees
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
pages
›
Blueteq High Cost Drug System
›
Blueteq accordion 2
Blueteq accordion 2
09/08/2023
What is the difference between a treatment initiation form and a continuation form?
09/08/2023
Do I need to complete a treatment initiation form for current patients once Blueteq HCD goes live in NHS Wales?
09/08/2023
How will the data collected through Blueteq HCD be used?
09/08/2023
Who will have access to the data collected through Blueteq HCD?
09/08/2023
Will providers who already use Blueteq HCD in NHS England, need a second log-in to the NHS Wales Blueteq HCD system, to fill in funding applications for patients in Wales?
09/08/2023
How will Blueteq HCD forms be created for a medicine?
09/08/2023
Has NHS Wales engaged the clinical community for each disease area on how Blueteq HCD and subsequent prescribing will fit into a patient treatment pathway?
09/08/2023
Is there a Blueteq HCD user guide?
09/08/2023
Who do I contact if I have a query about filling in a form, or want to suggest an improvement to it?
09/08/2023
Who do I contact if I have technical problems with Blueteq HCD?
Follow AWTTC: